Skip to main content

Table 2 T0, T1, T2 and peak urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 concentrations by serum creatinine-based RIFLE status within 48 hours following admissiona

From: Urinary neutrophil gelatinase-associated lipocalin identifies critically ill young children with acute kidney injury following intensive care admission: a prospective cohort study

Measurement, number of patients

Non-AKI, n = 65

RIFLE-Risk, n = 15

RIFLE-Injury, n = 10

RIFLE-Failure, n = 10

P -value

T0, 0 to 6 hr

     

  uNGAL (ng/ml), n = 59

31 (16 to 111)

396 (70to 1,250)

385 (77 to 1,987)

1,873 (484 to 3,936)

<0.001

  KIM-1 (ng/ml), n = 59

0.11 (0.08 to 0.19)

0.18 (0.13 to 0.28)

0.10 (0.08 to 0.11)

1.2 (0.4 to 3.5)

0.004

T1, 6 to 12 hr

     

  uNGAL (ng/ml), n = 85

21 (8 to 116)

114 (61 to 420)

275 (11 to 4630)

2430 (727 to 6000)

<0.001

  KIM-1 (ng/ml), n = 85

0.11 (0.08 to 0.27)

0.10 (0.08 to 0.29)

0.12 (0.08 to 0.16)

0.35 (0.29 to 1.21)

0.018

T2, 12 to 24 hr

     

  uNGAL (ng/ml), n = 95

22 (10 to 98)

34 (22 to 200)

47 (26 to 1935)

979 (301 to 6000)

0.001

  KIM-1 (ng/ml), n = 93

0.16 (0.08 to 0.28)

0.26 (0.11 to 0.56)

0.30 (0.12 to 0.41)

0.47 (0.26 to 2.15)

0.002

24-hr peak level

     

  uNGAL (ng/ml), n = 100

59 (16 to 136)

225 (89 to 730)

385 (56 to 3938)

1495 (387 to 6000)

<0.001

  KIM-1 (ng/ml), n = 100

0.17 (0.08 to 0.34)

0.26 (0.11 to 0.56)

0.25 (0.10 to 0.41)

0.86 (0.44 to 2.15)

0.001

  1. aAKI, Acute kidney injury; KIM-1, Kidney injury molecule-1; RIFLE, Risk, injury, failure, loss, end-stage renal disease; SCr, Serum creatinine; uNGAL, Urinary neutrophil gelatinase-associated lipocalin. Data are expressed as median (interquartile range). P-values indicate overall comparison of all groups (that is, non-AKI versus Risk versus Injury versus Failure). Intergroup differences were assessed using the Kruskal-Wallis test. RIFLE categories risk, injury and failure were defined as, respectively, serum creatinine (SCr) above 150%, 200% and 300% of the median age-specific SCr reference values.